Wegovy, which contains semaglutide, is one of several GLP-1 receptor agonists on the market
GLP-1 produces a direct suppression of POMC neurons in the appetite control center of the brain, leading to suppression of appetite
The pattern is consistent: researchers who use a mix IGF-1 LR3 calculator before touching the vial achieve dose accuracy within 5mcg
Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs GLP-1 Analogues: Mechanism, Indications, and Side Effects GLP-1 Analogues : Definition Synthetic versions of the natural hormone GLP-1 (glucagon-like peptide-1) that are resistant to DPP-4 breakdown, providing longer-lasting effects
234,235 All these data corroborate the oncogenic role of SIRT1, which strongly depends on the NAD + pool and NAMPT activity
, Pollak M
.webp)
